메뉴 건너뛰기




Volumn 41, Issue 7, 2006, Pages 862-865

Treatment of hepatic hydrothorax with terlipressin in a cirrhotic patient

Author keywords

Hepatorenal syndrome; Hydrothorax; Terlipressin

Indexed keywords

ANTIBIOTIC AGENT; FUROSEMIDE; HYDROCHLOROTHIAZIDE; OCTREOTIDE; TERLIPRESSIN;

EID: 33745331975     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.1080/00365520500527441     Document Type: Article
Times cited : (22)

References (19)
  • 1
    • 4444231927 scopus 로고    scopus 로고
    • Hepatic hydrothorax: Pathophysiology, diagnosis and treatment. A review of the literature
    • Gur C, Ilan Y, Shibolet O. Hepatic hydrothorax: pathophysiology, diagnosis and treatment. A review of the literature. Liver Int 2004;24:281-4.
    • (2004) Liver Int , vol.24 , pp. 281-284
    • Gur, C.1    Ilan, Y.2    Shibolet, O.3
  • 3
    • 9244238212 scopus 로고    scopus 로고
    • Hepatic hydrothorax in the absence of ascites; respiratory failure in a cirrhotic patient
    • Serrat J, Roza JJ, Planella T. Hepatic hydrothorax in the absence of ascites; respiratory failure in a cirrhotic patient. Anesth Analg 2004;99:1803-4.
    • (2004) Anesth Analg , vol.99 , pp. 1803-1804
    • Serrat, J.1    Roza, J.J.2    Planella, T.3
  • 4
    • 0346118829 scopus 로고    scopus 로고
    • Hepatic hydrothorax: Pathophysiology, diagnoses and management
    • Garcia N Jr, Mihas AA. Hepatic hydrothorax: pathophysiology, diagnoses and management. J Clin Gastroenterol 2004;38:52-8.
    • (2004) J Clin Gastroenterol , vol.38 , pp. 52-58
    • Garcia Jr., N.1    Mihas, A.A.2
  • 6
    • 0036514272 scopus 로고    scopus 로고
    • Percutaneous intrahepatic portosystemic shunting as a treatment for refractory hepatic hydrothorax
    • Nunez O, Garcia A, Rincon D, Alonso S, Echenagusia A, Banares R. Percutaneous intrahepatic portosystemic shunting as a treatment for refractory hepatic hydrothorax. Gastroenterol Hepatol 2002;25:143-7.
    • (2002) Gastroenterol Hepatol , vol.25 , pp. 143-147
    • Nunez, O.1    Garcia, A.2    Rincon, D.3    Alonso, S.4    Echenagusia, A.5    Banares, R.6
  • 7
    • 13944260896 scopus 로고    scopus 로고
    • Hepatorenal syndrome: A dreaded complication of end stage liver disease
    • Cardenas A. Hepatorenal syndrome: a dreaded complication of end stage liver disease. Am J Gastroenterol 2005;100: 460-7.
    • (2005) Am J Gastroenterol , vol.100 , pp. 460-467
    • Cardenas, A.1
  • 9
    • 0038531139 scopus 로고    scopus 로고
    • Transjugular intrahepatic portosystemic shunt: Current status
    • Boyer TD. Transjugular intrahepatic portosystemic shunt: current status. Gastroenterology 2003;124:1700-10.
    • (2003) Gastroenterology , vol.124 , pp. 1700-1710
    • Boyer, T.D.1
  • 12
    • 0036787604 scopus 로고    scopus 로고
    • Terlipressin therapy with or without albumin for patients with hepatorenal syndrome: Results of a prospective nonrandomized study
    • Ortega R, Gines P, Uriz J, Caerdenas A, Calahorra B, Heras DDL, et al. Terlipressin therapy with or without albumin for patients with hepatorenal syndrome: results of a prospective nonrandomized study. Hepatology 2002;36:941-8.
    • (2002) Hepatology , vol.36 , pp. 941-948
    • Ortega, R.1    Gines, P.2    Uriz, J.3    Caerdenas, A.4    Calahorra, B.5    Ddl, H.6
  • 13
    • 0033916288 scopus 로고    scopus 로고
    • Terlipressin plus albumin infusion: An effective and safe therapy of hepatorenal syndrome
    • Uriz J, Gines P, Cardenas A, Sort P, Jimenes W, Salmeron JM, et al. Terlipressin plus albumin infusion: an effective and safe therapy of hepatorenal syndrome. J Hepatol 2000;33: 43-8.
    • (2000) J Hepatol , vol.33 , pp. 43-48
    • Uriz, J.1    Gines, P.2    Cardenas, A.3    Sort, P.4    Jimenes, W.5    Salmeron, J.M.6
  • 14
    • 1642439103 scopus 로고    scopus 로고
    • Systemic, portal and renal effects of terlipressin in patients with cirrhotic ascites: Pilot study
    • Therapondos G, Stanley AJ, Hayes PC. Systemic, portal and renal effects of terlipressin in patients with cirrhotic ascites: pilot study. J Gastroenterol Hepatol 2004;19:73-7.
    • (2004) J Gastroenterol Hepatol , vol.19 , pp. 73-77
    • Therapondos, G.1    Stanley, A.J.2    Hayes, P.C.3
  • 17
    • 3042696433 scopus 로고    scopus 로고
    • Midodrine, octreotide, albumin and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome
    • Wong F, Pantea L, Sniderman K. Midodrine, octreotide, albumin and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome. Hepatology 2004;40:55-64.
    • (2004) Hepatology , vol.40 , pp. 55-64
    • Wong, F.1    Pantea, L.2    Sniderman, K.3
  • 19
    • 20144389166 scopus 로고    scopus 로고
    • Acute hemodynamic effects of octreotide and terlipressin in patients with cirrhosis: A randomized comparison
    • Baik SK, Jeong PH, Ji SW, Yoo BS, Kim HS, Lee DK, et al. Acute hemodynamic effects of octreotide and terlipressin in patients with cirrhosis: a randomized comparison. Am J Gastroenterol 2005;100:631-5.
    • (2005) Am J Gastroenterol , vol.100 , pp. 631-635
    • Baik, S.K.1    Jeong, P.H.2    Ji, S.W.3    Yoo, B.S.4    Kim, H.S.5    Lee, D.K.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.